Cellectar Biosciences Inc (NASDAQ: CLRB) flaunted slowness of -5.58% at $3.63, before settling in for the price of $3.85 at the close. Taking a more long-term approach, CLRB posted a 52-week range of $1.30-$4.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 43.13%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 57.23%. This publicly-traded company’s shares outstanding now amounts to $20.74 million, simultaneously with a float of $11.13 million. The organization now has a market capitalization sitting at $44.67 million. At the time of writing, stock’s 50-day Moving Average stood at $3.68, while the 200-day Moving Average is $2.62.
Cellectar Biosciences Inc (CLRB) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Cellectar Biosciences Inc industry. Cellectar Biosciences Inc’s current insider ownership accounts for 9.42%, in contrast to 79.73% institutional ownership.
Cellectar Biosciences Inc (CLRB) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2022, it has been observed that the corporation posted -$1.28 earnings per share (EPS) during the time that was less the consensus figure (set at -$1.21) by -$0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
Cellectar Biosciences Inc’s EPS increase for this current 12-month fiscal period is 57.23% and is forecasted to reach -0.39 in the upcoming year.
Cellectar Biosciences Inc (NASDAQ: CLRB) Trading Performance Indicators
Let’s observe the current performance indicators for Cellectar Biosciences Inc (CLRB). It’s Quick Ratio in the last reported quarter now stands at 0.81. The Stock has managed to achieve an average true range (ATR) of 0.27.
In the same vein, CLRB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.11, a figure that is expected to reach -0.40 in the next quarter, and analysts are predicting that it will be -0.39 at the market close of one year from today.
Technical Analysis of Cellectar Biosciences Inc (CLRB)
Now, what If we examine the latest scores posted by [Cellectar Biosciences Inc, CLRB]. During the last 5-days, its volume was lower the volume of 1.88 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 53.05% While, its Average True Range was 0.28.
Raw Stochastic average of Cellectar Biosciences Inc (CLRB) in the period of the previous 100 days is set at 68.41%, which indicates a major rise in contrast to 32.76% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 76.87% that was lower than 80.20% volatility it exhibited in the past 100-days period.
